However, when we focused on the aggressive genetic subtypes of MM, we found that in the MMSET subgroup, the presence of both SMPD1 and SMPD4 separately present a group of ultra-high-risk MM with a PFS of about one year. This evidence concerns the gene SMPD1 and Miyoshi myopathy.